ATG2A and glioblastoma: Downregulation of ATG2A inhibited the proliferation (Fig. 3K, Supplementary Fig. 3D) and migration of GBM cells (Fig. 3L, Supplementary Fig. 3E) and promoted apoptosis of GBM cells (Fig. 3M, Supplementary Fig. 3F).